DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "World Intravenous (IV) Ibuprofen Market - Opportunities and Forecasts, 2015 - 2022" report to their offering.
The market for IV ibuprofen for pain management is in its nascent stage. It was valued at $3.6 million in 2015, and is projected to reach $14.2 million by 2022, registering a CAGR of 20% during the forecast period.
Advantages associated with IV ibuprofen such as rapid result and targeted drug delivery have resulted in the growth of this market. In 2015, FDA approved IV ibuprofen for pediatric use, due to which the market is expected to register a significant growth during the forecast period. Other factors that affect the market growth significantly include increasing incidence of cancer, cardiovascular ailments, pain, headache, toothache, back pain, arthritis, trauma, and shifting trend towards the use of non-opioids drugs.
Factors that would hamper the market growth include side effects associated with IV ibuprofen and lengthy approval process.
Geographically, North America and Asia-Pacific constitute the two largest markets for IVIG, collectively accounted for -75% of the market revenue in 2014. Higher adoption rates, large patient population, and the presence of largest plasma collection & manufacturing base are the key factors responsible for the growth of IVIG market in these regions. However, the market growth outlook across developing economies is also looking strong, owing to increasing awareness towards immunodeficiency and rare autoimmune diseases, favorable reimbursement initiatives and improved healthcare expenditure.
- Al Nabeel International Ltd.
- Alveda Pharmaceuticals Inc. (Acquired by Teligent Inc.)
- CSL Limited
- Cumberland Pharmaceuticals Inc
- Germin MED
- Grifols S.A.
- Harbin Gloria Pharmaceuticals Co. Ltd.
- Laboratorios Valmorca C.A
- Sandor Medicaids Pvt Ltd.
- Soho Industri Pharmasi
Key Topics Covered:
Chapter: 1 INTRODUCTION
Chapter: 2 EXECUTIVE SUMMARY
Chapter: 3 MARKET OVERVIEW
Chapter: 4 WORLD ANALGESICS MARKET, BY AGE GROUP, 2015-2022
Chapter: 5 WORLD ANALGESICS MARKET, BY INDICATION, 2015-2022
Chapter: 6 WORLD ANALGESICS MARKET, BY COUNTRY, 2015-2022
Chapter: 7 COMPANY PROFILES
For more information visit http://www.researchandmarkets.com/research/kwvzgj/world_intravenous